Bulk Pharmaceutical API Sources for CAPECITABINE

Bulk Pharmaceutical API Sources for CAPECITABINE

Vendor	Vendor Homepage	Vendor Sku	API Url
Molport		MolPort-005-938-254
Oakwood Products		048966
Amadis Chemical		A809528
BioChemPartner		BCPP000300
BioChemPartner		BCP9000483
AKos Consulting & Solutions		AKOS015920130

Bulk Active Pharmaceutical Ingredient (API) Sources for: CAPECITABINE

Last updated: July 31, 2025

Introduction

Capecitabine, marketed globally under brand names such as Xeloda, is an oral chemotherapeutic agent extensively utilized in the treatment of metastatic breast cancer, colorectal cancer, and other solid tumors. As an oral prodrug of 5-fluorouracil (5-FU), its manufacturing and procurement hinge on reliable sources of high-quality Active Pharmaceutical Ingredients (APIs). This article evaluates the global landscape of bulk API suppliers for capecitabine, analyzing their manufacturing footprints, regulatory adherence, and strategic relevance for pharmaceutical companies.

---

Overview of Capecitabine API

Capecitabine's chemical designation is 5'-deoxy-5-fluorocytidine, with the molecular formula C₁₅H₂₁N₃O₆. Its synthesis involves complex multi-step procedures starting from cytidine or related nucleoside analogs, necessitating stringent quality control to meet pharmaceutical standards such as those outlined by the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and other regional authorities.

High-grade APIs require adherence to Good Manufacturing Practices (GMP), rigorous purity, and consistency criteria, making supplier selection critical for drug quality, regulatory compliance, and supply chain robustness.

---

Major API Manufacturers for Capecitabine

1. Domestic Chinese Suppliers

China remains a dominant force in generic API manufacturing, attributed to extensive infrastructure, cost advantages, and capacity for high-volume production. Several Chinese companies are leading suppliers:

• Qingdao Sanlian Pharmaceutical Chemical Co., Ltd.
  Known for producing high-purity nucleoside analog APIs, including capecitabine, with GMP-certified facilities targeting global markets.

• Pingxiang Pharmaceutical Co., Ltd.
  Offers bulk APIs compliant with international standards, with extensive experience in complex nucleoside synthesis.

• Jiangxi Huayu Pharmaceutical Co., Ltd.
  Has attained regulatory approvals in various regions, supplying the API with consistent quality control protocols.

These suppliers often export to India, Europe, and North America, serving as core API providers for generics producers.

2. Indian API Manufacturers

India is recognized for its robust pharmaceutical manufacturing ecosystem, emphasizing cost-effective, high-quality APIs:

• Cipla Limited
  A pioneer in the Indian pharmaceutical sector, Cipla supplies both finished formulations and bulk APIs, including capecitabine, with GMP-certified manufacturing capacities.

• Sun Pharmaceuticals
  Engaged in API production with specific focus on nucleoside analogs, Sun maintains strict regulatory compliance aligned with USFDA and EMA standards.

• Aurobindo Pharma
  Known for its expansive API portfolio, including advanced nucleoside APIs, with dedicated export channels to regulated markets.

• Laurus Labs
  Recognized for high-volume API manufacturing, including complex molecules such as capecitabine, with certification for global distribution.

Indian manufacturers benefit from competitive pricing and adherence to international standards, making them preferred partners for large-scale procurement.

3. European and U.S. API Suppliers

While Europe and North America do not host many dedicated capecitabine API manufacturers due to higher production costs, some specialized players and CMOs (Contract Manufacturing Organizations) offer high-quality APIs:

• Evonik Industries
  A German multinational with capabilities in complex nucleosides, focusing on custom synthesis and GMP APIs.

• NorthStar Rx LLC
  Based in the United States, providing GMP-compliant nucleoside APIs, including capecitabine, with robust regulatory documentation.

• Bachem AG
  With a strong presence in peptide and nucleoside synthesis, Bachem supplies intermediates and APIs for research and small-scale production, emphasizing quality and regulatory adherence.

These suppliers serve niche markets or bespoke pharmaceutical applications where stringent quality assurance is critical.

---

Key Factors Influencing API Source Selection

• Regulatory Compliance: Suppliers must meet GMP standards aligned with regional authorities, such as the USFDA, EMA, or PIC/S guidelines. Regulatory audits and certifications (e.g., ISO) are essential.

• Quality Assurance: High-purity API (>99%) with well-documented stability profiles minimizes the risk of batch failures and accelerates approval processes.

• Capacity & Reliability: Sufficient manufacturing scale and supply chain resilience are vital to avoid shortages, especially given the global demand for chemotherapeutic agents.

• Cost & Lead Time: Competitive pricing and shorter procurement lead times enhance supply chain efficiency but should not compromise quality standards.

---

Emerging Trends and Strategic Considerations

• Localization of API Manufacturing: Increasing regional API production capacities aims to reduce reliance on certain geographies, mitigate geopolitical risks, and meet regional regulatory demands.

• Vertical Integration & R&D: Some pharmaceutical companies invest in developing their synthetic routes or even establishing in-house API manufacturing, fostering supply chain independence.

• Supply Chain Diversification: Diversifying sources across Chinese, Indian, and Western suppliers enhances supply security and pricing competitiveness.

• Regulatory Stringency & Quality Upgrades: As global regulatory agencies tighten standards, suppliers investing in upgrade certifications gain competitive edge.

---

Conclusion

The landscape for bulk capecitabine API sourcing encompasses a diverse array of Chinese, Indian, European, and North American suppliers. Chinese and Indian manufacturers dominate the global supply chain with GMP-compliant, cost-effective, high-volume APIs suited for generic drug manufacturing. European and U.S.-based suppliers primarily target high-purity, regulated markets, offering suppliers with advanced quality control and regulatory assurance.

For pharmaceutical companies, strategic sourcing involves balancing price, quality, regulatory compliance, and supply chain reliability. Amid evolving regulations and market dynamics, diversifying API sources remains crucial to ensuring uninterrupted supply and maintaining the integrity of capecitabine-based therapeutics.

---

Key Takeaways

• Chinese and Indian suppliers dominate the capecitabine API market, offering substantial production capacity and cost advantages, with strict adherence to GMP standards.

• Regulatory compliance is paramount; suppliers with certifications aligned with USFDA, EMA, or other authorities are preferred.

• Quality, capacity, and reliability significantly influence procurement decisions amid growing supply chain complexity.

• European and North American API suppliers serve niche markets requiring high purity and stringent regulatory adherence.

• Diversification and strategic partnerships are essential for mitigating geopolitical and supply risks in sourcing capecitabine APIs.

---

FAQs

Q1: What are the primary regulatory requirements for sourcing capecitabine APIs?
Regulatory requirements include GMP certification, comprehensive quality documentation, stability data, and compliance with regional pharmacopoeias such as USP or EP. Suppliers must also undergo regulatory audits to verify manufacturing standards.

Q2: How do Chinese and Indian API suppliers compare in quality standards?
Both regions have suppliers that meet international GMP standards, including certifications from USFDA, EMA, or PIC/S. Indian suppliers often emphasize compliance with WHO-GMP, while Chinese suppliers have increasingly upgraded to meet global standards, offering high-quality APIs suitable for regulated markets.

Q3: Is it feasible to source capecitabine API from North American or European manufacturers?
Yes, although options are fewer, these suppliers typically focus on high-purity APIs for specialized niche markets, often at higher costs. Their advantages include rigorous regulatory oversight and advanced manufacturing techniques.

Q4: What are the key factors influencing the choice of API suppliers for capecitabine?
Factors include regulatory compliance, API quality and purity, manufacturing capacity, lead times, cost, and the supplier’s reliability and reputation within the pharmaceutical industry.

Q5: Are there any recent trends impacting capecitabine API sourcing?
Trends include increased localization of API production, investments in manufacturing upgrades, diversification of suppliers, and efforts to ensure supply chain resilience amid geopolitical uncertainties and regulatory changes.

---

References

[1] United States Pharmacopeia (USP): Monograph for Capecitabine.
[2] European Pharmacopoeia (EP).
[3] Industry reports on global nucleoside API manufacturing capacity.
[4] Company websites: Qingdao Sanlian Pharmaceutical, Cipla, Sun Pharmaceuticals, Evonik.
[5] Market trend analyses on pharmaceutical raw material sourcing.